Medical network May 4 - May 2, drug trading center of guangdong province announced on the website are not in accordance with the contract delivery, and failed to timely supply list, request production enterprise timely supply distribution within ten days. Reporter noted that drug trading center of guangdong province announced 1004 product rules of drugs is not supply or supply timely, involving 135 drug firms, 68 drug, new low-cost medicine to reach 335 kinds, accounted for more than thirty percent of the total. 

 

Over 1,000 medicines are broken for the guangdong market 

 

On May 2, drug trading center in the official website of guangdong province hanging out on the drug trade in the fifth batch of supply is not in accordance with the contract and enterprises failed to timely supply of the public ", all the production and distribution enterprises in the public notice period (17:00 on May 2 ~ 12) for not supply and timely supply of varieties, timely supply and distribution. 

 

Among them, both the baiyun mountain (600332, shares), yunnan baiyao (000538, shares), national medicine, medicine group, the Yangtze pharmaceutical, and other well-known production enterprise, also have cr medicine, its holdings, the broad medicine group distribution companies such as leader. Huang shanxiang, secretary general of the pharmaceutical circulation association of hunan province, told reporters that guangdong is a big province of medicine, but that the price of the winning bid has been "lethal" across the country. Once drug companies are able to survive in guangdong's drug tenders, it is difficult to find bids in the rest of the country. 

 

"Daily economic news" reporter in the covering 1004 gauge drug list to see, just note for the amount of new low-priced drugs reached 335, accounting for 33.37% of the total list, and other basic drugs of medicine, 283, 32 of clinical must and procurement difficulties. 

 

However, the guangdong pharmaceutical trading center did not specify "contract supply" and "untimely supply" in the list. On May 3rd, reporters repeatedly called the trading center to open the phone, and no one answered the phone as of press time. Later, the reporter called the guangdong health and family planning commission, which said it was unclear what the drug trading center was doing. 

 

Agent: the cost goes up 

 

Although companies won the bid is not supply from year to year, but thousands of drug released drug trading center in guangdong province appear out of stock situation, reflecting the production enterprises in the low bid after the dilemma between public welfare and interests. 

 

Journalists know that some medicines are tendering because companies feel unprofitable. Some companies have won the bid; There is also a Chinese company that doesn't think it's worth it, but it doesn't produce it on the Internet, so it doesn't buy it. Some businesses are unable to make money, and the production of drug production expires and does not register. 

 

"There are a lot of places where it is the case that companies are not producing because of the cost." Huang Xiuxiang said, according to his understanding, pharmaceutical production costs continue to rise in recent years, the bid price is on the decline, some proprietary Chinese medicine have increased five or six times the cost of production, once the enterprise production means losing money, it is also in recent years, many famous the crux of the shortage of cheap drugs. 

 

"Some for cost reasons not production, some enterprises are also think the price is too low, the bid price of guangdong province and the national linkage, low prices will lower profits, just out." Mr Huang points out that the profits generated by prices are not attractive or even at a loss, and that companies are not willing to produce. Some drug production costs have more than five-sixfold in recent years, so companies prefer to forgo supply rather than increase losses. The government needs to find ways to make companies willing to produce cheap medicines with word of mouth and good results, and make changes in policy to make them profitable.